Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentary
Masoud Jamei, Bertil Abrahamsson, Jonathan Brown, Jan Bevernage, Michael B. Bolger, Tycho Heimbach, Εva Karlsson, Evangelos Kotzagiorgis, Anders Lindahl, Mark McAllister, James M. Mullin, Xavier Pépin, Christophe Tistaert, David B. Turner, Filippos Kesisoglou
Topics & Concepts
Physiologically based pharmacokinetic modellingBiopharmaceuticsDissolutionBiopharmaceutics Classification SystemBiochemical engineeringDissolution testingIVIVCDrugComputer sciencePharmacokineticsProcess (computing)ChemistryPharmacologyMedicineEngineeringIn vitroOperating systemBiochemistryPhysical chemistryBiological activityPharmacognosyDrug Solubulity and Delivery SystemsCrystallization and Solubility StudiesAnalytical Chemistry and Chromatography